CN101972351B - Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura - Google Patents
Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura Download PDFInfo
- Publication number
- CN101972351B CN101972351B CN2010102968733A CN201010296873A CN101972351B CN 101972351 B CN101972351 B CN 101972351B CN 2010102968733 A CN2010102968733 A CN 2010102968733A CN 201010296873 A CN201010296873 A CN 201010296873A CN 101972351 B CN101972351 B CN 101972351B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- blood
- thrombocytopenia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura, which is prepared from the following raw material medicines in part by weight: 8 to 12 parts of suberect spatholobus stem, 6 to 10 parts of Japanese thistle herb, 4 to 8 parts of common cephalanoplos herb, 3 to 7 parts of carbonized human hair, 1 to 3 parts of ginseng, 1 to 5 parts of rhubarb, 1 to 5 parts of hairyvein agrimonia herb, 1 to 3 parts of donkey-hide gelatin, 1 to 5 parts of wolfberry fruit and 1 to 3 parts of Chinese date. The traditional Chinese medicine has the effects of enriching the blood, stopping bleeding, nourishing the blood and tranquilizing, thereby effectively and radically treating thrombocytopenia. The medicine is pure traditional Chinese medicinal preparation and does not have any toxic or side effect.
Description
Technical field
The present invention relates to technical field of Chinese medicines, relate in particular to a kind of Chinese medicine for the treatment of thrombocytopenia, allergic purpura.
Background technology
Purpura is meant mucocutaneous and the hemorrhage formed petechia ecchymosis of internal organs.Primary disease can be divided into thrombocytopenic purpura and anaphylactoid purpura two big classes.Thrombocytopenic purpura is meant because of thrombocytopenia causes blood coagulation disorder and takes place, can be divided into two kinds of constitutional and Secondary cases.Anaphylactoid purpura is a kind of allergic disease that is caused by allergy.
The clinical manifestation of the two is Mucocutaneous hemorrhage ecchymosis, arthralgia, stomachache etc. often.
Purpura is more common in child and youth, is because blood oozes out outside blood vessel, at skin and mucosa generation petechia or ecchymosis.Purpura is not only dermatorrhagia, also can organize internal hemorrhage, is formed with the hematoma of fluctuation, and serious patient also can be hemorrhage at gastrointestinal and kidney.
Summary of the invention
Technical problem to be solved by this invention provides and a kind ofly enriches blood, hemostasis, the treatment thrombocytopenia of nourishing blood to tranquillize the mind, the Chinese medicine of allergic purpura.
For solving the problems of the technologies described above, technical scheme of the present invention is: a kind of Chinese medicine for the treatment of thrombocytopenia, allergic purpura, and it is to be made by following bulk drugs:
Caulis Spatholobi 8～12, Radix Cirsii Japonici 6～10, Herba Cirsii 4～8, Crinis Carbonisatus 3～7, Radix Ginseng 1～3, Radix Et Rhizoma Rhei 1～5, Herba Agrimoniae 1～5, Colla Corii Asini 1～3, Fructus Lycii 1～5, Fructus Jujubae 1～3.
As optimized technical scheme, a kind of Chinese medicine for the treatment of thrombocytopenia, allergic purpura is to be made by following bulk drugs:
Caulis Spatholobi 8～12g, Radix Cirsii Japonici 6～10g, Herba Cirsii 4～8g, Crinis Carbonisatus 3～7g, Radix Ginseng 1～3g, Radix Et Rhizoma Rhei 1～5g, Herba Agrimoniae 1～5g, Colla Corii Asini 1～3g, Fructus Lycii 1～5g, Fructus Jujubae 1～3g.
As another optimized technical scheme, a kind of Chinese medicine for the treatment of thrombocytopenia, allergic purpura is to be made by following bulk drugs:
Caulis Spatholobi 10, Radix Cirsii Japonici 8, Herba Cirsii 6, Crinis Carbonisatus 5, Radix Ginseng 2, Radix Et Rhizoma Rhei 3, Herba Agrimoniae 3, Colla Corii Asini 2, Fructus Lycii 3, Fructus Jujubae 2.
Caulis Spatholobi, nature and flavor: bitter, sweet, temperature;
Function cures mainly: enrich blood, invigorate blood circulation, collateral dredging.Be used for menoxenia, blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia.
Radix Cirsii Japonici, nature and flavor: sweet, cool, nontoxic;
Function cures mainly: control haematemesis, epistaxis, hematuria, stranguria with blood, metrorrhagia, leukorrhagia, hemorrhoidal hamorrhage, acute appendicitis, carbuncle and ulcer toxic swelling, furuncle.
Herba Cirsii, nature and flavor: sweet, bitter, cold;
Function cures mainly: cooling blood for hemostasis, removing blood stasis to reduce swelling.Be used for epistaxis, spit blood, hematuria is had blood in stool, metrostaxis, traumatic hemorrhage, carbuncle sore tumefacting virus.
Crinis Carbonisatus, nature and flavor: bitter, tepor;
Function cures mainly: repercussive, hemostasis, diuresis.Cure mainly cards such as haematemesis, epistaxis, dysentery, stranguria with blood, woman uterine bleeding and dysuria.Endure cream external application hemostasia and promoting granulation.
Radix Ginseng, nature and flavor: property is flat, sweet in the mouth, little hardship, tepor;
Function cures mainly: strongly invigorating primordial QI, multiple arteries and veins takes off invigorating the spleen to benefit the lung, promoting the production of body fluid to quench thirst, the Fructus Alpiniae Oxyphyllae of calming the nerves admittedly.
Radix Et Rhizoma Rhei, nature and flavor: hardship, cold;
Function cures mainly: attack stagnant; Clearing away damp-heat; Pathogenic fire purging; Removing heat from blood; Blood stasis dispelling; Detoxifcation; Cure mainly the excess-heat constipation; The accumulation of heat feeling of stuffiness in chest; Damp-heat dysentery; Jaundice; Gonorrhea; The edema abdominal distention; Dysuria; Conjunctival congestion; Laryngopharynx swelling and pain; Aphtha of the mouth and tongue; Gastropyretic vomiting; Spit blood; Spitting of blood; Epistaxis; Have blood in stool; Hematuria; Blood-retention; Amenorrhea; The stasis of blood stagnated and suffered from abdominal pain puerperal; Lump in the abdomen; Traumatic injury; Pyretic toxicity carbuncle and ulcer; Erysipelas; Scald.
Herba Agrimoniae, nature and flavor: property is flat, bitter in the mouth, puckery;
Function cures mainly: astringing to arrest bleeding, preventing the attack (or recurrence) of malaria, dysentery relieving, detoxifcation; Be used for hemoptysis, haematemesis, malaria, take off power impairment caused by overstrain, carbuncle.
Colla Corii Asini, nature and flavor: sweet, flat;
Function cures mainly: enriches blood, and hemostasis, nourshing Yin and drynsessmoistening prescription.
Fructus Lycii, function cures mainly: the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, blood-enriching tranquillizing, promoting the production of body fluid to quench thirst, nourishing the lung to arrest cough; The treating the liver kidney yin is lost, soreness of the waist and knees, and dizziness, dizzy, the many tears of blurred vision, cough due to consumptive disease is quenched one's thirst, seminal emission.
Fructus Jujubae, nature and flavor: sweet, temperature;
Function cures mainly: invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind.Be used for insufficiency of the spleen lack of appetite, weak loose stool, woman hysteria.
Radix Ginseng is as monarch drug, and Caulis Spatholobi, Radix Cirsii Japonici, Herba Cirsii, Crinis Carbonisatus, Herba Agrimoniae, Fructus Lycii are as ministerial drug, and Colla Corii Asini, Fructus Jujubae are as left dispenser, and Radix Et Rhizoma Rhei is as priming.
Described Chinese medicine is decoction, pill, tablet or dissolved granule, can be according to the method for routine, described crude drug is decocted with water, make decoction, make pill after also described crude drug can being ground to form fine powder, as add water and make the watered pill or add processed with honey and get honeyed pill, make tablet or dissolved granule after described crude drug can certainly being ground to form fine powder.
Usage and consumption: pill, tablet or electuary are taken 5～10g at every turn, every day three times.
Owing to adopted technique scheme, a kind of Chinese medicine for the treatment of thrombocytopenia, allergic purpura, it is to be made by following bulk drugs: Caulis Spatholobi 8～12, Radix Cirsii Japonici 6～10, Herba Cirsii 4～8, Crinis Carbonisatus 3～7, Radix Ginseng 1～3, Radix Et Rhizoma Rhei 1～5, Herba Agrimoniae 1～5, Colla Corii Asini 1～3, Fructus Lycii 1～5, Fructus Jujubae 1～3; Chinese medicine of the present invention is enriched blood, hemostasis, nourishing blood to tranquillize the mind can suppress thrombocytopenia effectively, thereby plays the basic goal of treatment, and this medicine is that pure Chinese medicinal preparation is without any side effects.
Further specify the present invention below in conjunction with concrete case:
Grandson, the woman, 59 years old now, people from Qingzhou, Weifang, in I go to a doctor at institute over 2008, blood RT showed at that time: PLT (platelet) 55 109/L are thrombocytopenia after diagnosing, adopt medicine pill treatment of the present invention to fully recover after 1 year.
Lian, woman, 17 years old now, people from Henan, now live Beijing, in I go to a doctor at institute over 2008, blood RT showed at that time: PLT 20 109/L, adopt Chinese medicinal tablet treatment of the present invention, treat after 1 year, existing PLT technology is in normal model position, and now drug withdrawal 1 year is surplus, and the PLT technology is normal always.
High certain, the woman, 36 years old now, the Dongying City people came my institute to go to a doctor on August 3rd, 2010, be diagnosed as: blood PT shows PLT 55 109/L, adopt Chinese medicine electuary treatment two weeks of the present invention after, the PLT technology after normal range, the existing continuation with my institute's Drug therapy.
Hu, the woman, 28 years old now, people from Hunan went to a doctor in my institute over 2007, and blood RT showed at that time: PLT20 109/L, adopt Chinese medicinal tablet treatment of the present invention, treat after 1 year, existing PLT technology is in normal model position, and now drug withdrawal 2 years is surplus, and the PLT technology is normal always.
The specific embodiment
Below in conjunction with embodiment, further set forth the present invention.Should be understood that these embodiment only to be used to the present invention is described and be not used in and limit the scope of the invention.Should be understood that in addition those skilled in the art can make various changes or modifications the present invention after the content of having read the present invention's instruction, these equivalent form of values fall within the application's appended claims institute restricted portion equally.
Embodiment one:
Get Caulis Spatholobi, 6g Radix Cirsii Japonici, 4g Herba Cirsii, Crinis Carbonisatus 3g, 1g Radix Ginseng, 1g Radix Et Rhizoma Rhei, 1g Herba Agrimoniae, 1g Colla Corii Asini, 1g Fructus Lycii, the 1g Fructus Jujubae of 8g, decoct with water, make the decoction of the Chinese medicine of described treatment thrombocytopenia, allergic purpura.
Embodiment two:
Get 10g Caulis Spatholobi, 8g Radix Cirsii Japonici, 6g Herba Cirsii, Crinis Carbonisatus 5g, 2g Radix Ginseng, 3g Radix Et Rhizoma Rhei, 3g Herba Agrimoniae, 2g Colla Corii Asini, 3g Fructus Lycii, 2g Fructus Jujubae, grind to form smalls, add afterwards water make described treatment thrombocytopenia, allergic purpura Chinese medicine the watered pill or add the honeyed pill that Mel is made the Chinese medicine of described treatment thrombocytopenia, allergic purpura.
Embodiment three:
Get 12g Caulis Spatholobi, 10g Radix Cirsii Japonici, 8g Herba Cirsii, Crinis Carbonisatus 7g, 3g Radix Ginseng, 5g Radix Et Rhizoma Rhei, 5g Herba Agrimoniae, 3g Colla Corii Asini, 5g Fructus Lycii, 3g Fructus Jujubae, grind to form smalls, be pressed into afterwards described treatment thrombocytopenia, allergic purpura Chinese medicine tablet or make the dissolved granule of the Chinese medicine of described treatment thrombocytopenia, allergic purpura.
More than show and described ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; that describes in the foregoing description and the description just illustrates principle of the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.
All from the present invention is to devise, the reconfiguration of having done without creative work all drops within protection scope of the present invention.
Claims (4)
1. a Chinese medicine for the treatment of thrombocytopenia, allergic purpura is characterized in that, it is to be made by following bulk drugs:
Caulis Spatholobi 8～12, Radix Cirsii Japonici 6～10, Herba Cirsii 4～8, Crinis Carbonisatus 3～7, Radix Ginseng 1～3, Radix Et Rhizoma Rhei 1～5, Herba Agrimoniae 1～5, Colla Corii Asini 1～3, Fructus Lycii 1～5, Fructus Jujubae 1～3.
2. a kind of Chinese medicine for the treatment of thrombocytopenia, allergic purpura as claimed in claim 1 is characterized in that, it is to be made by following bulk drugs:
Caulis Spatholobi 8～12g, Radix Cirsii Japonici 6～10g, Herba Cirsii 4～8g, Crinis Carbonisatus 3～7g, Radix Ginseng 1～3g, Radix Et Rhizoma Rhei 1～5g, Herba Agrimoniae 1～5g, Colla Corii Asini 1～3g, Fructus Lycii 1～5g, Fructus Jujubae 1～3g.
3. a kind of Chinese medicine for the treatment of thrombocytopenia, allergic purpura as claimed in claim 1 is characterized in that, it is to be made by following bulk drugs:
Caulis Spatholobi 10, Radix Cirsii Japonici 8, Herba Cirsii 6, Crinis Carbonisatus 5, Radix Ginseng 2, Radix Et Rhizoma Rhei 3, Herba Agrimoniae 3, Colla Corii Asini 2, Fructus Lycii 3, Fructus Jujubae 2.
4. as claim 2 or 3 described a kind of Chinese medicines for the treatment of thrombocytopenia, allergic purpura, it is characterized in that: described Chinese medicine is decoction, pill, tablet or dissolved granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102968733A CN101972351B (en) | 2010-09-27 | 2010-09-27 | Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102968733A CN101972351B (en) | 2010-09-27 | 2010-09-27 | Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101972351A CN101972351A (en) | 2011-02-16 |
| CN101972351B true CN101972351B (en) | 2011-10-05 |
Family
ID=43572281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102968733A Expired - Fee Related CN101972351B (en) | 2010-09-27 | 2010-09-27 | Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101972351B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526514B (en) * | 2011-11-12 | 2014-02-05 | 赵增 | Medicine used for treating allergic purpura |
| CN104000991A (en) * | 2014-05-16 | 2014-08-27 | 陈洪佳 | Mixed traditional Chinese medicine treating primary thrombocytopenic purpura |
| CN104740414A (en) * | 2015-04-21 | 2015-07-01 | 王雪雁 | Traditional Chinese medicine preparation for treating anaphylactoid purpura and preparation technology of traditional Chinese medicine preparation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101214324A (en) * | 2008-01-02 | 2008-07-09 | 荣玉明 | Chinese medicine prescription for treating chronic granulocytic leukemia patients and preparation |
-
2010
- 2010-09-27 CN CN2010102968733A patent/CN101972351B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101214324A (en) * | 2008-01-02 | 2008-07-09 | 荣玉明 | Chinese medicine prescription for treating chronic granulocytic leukemia patients and preparation |
Non-Patent Citations (3)
| Title |
|---|
| 孙凤.原发性血小板减少性紫癜中医治疗概况.《中医药信息》.2004,第21卷(第4期), * |
| 邵莉.孙轶秋治疗过敏性紫癜经验拾撷.《北京中医》.2007,第26卷(第11期), * |
| 陈洪洲.中西医结合治疗原发性血小板减少性紫癜60例总结.《湖南中医杂志》.2008,第24卷(第3期), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101972351A (en) | 2011-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103751570A (en) | Orally taken traditional Chinese medicine for treating migraine | |
| CN105079279A (en) | Traditional Chinese medicine for treating constipation | |
| CN104043057A (en) | Traditional Chinese medicinal composition for treating lymph cancer | |
| CN104043054A (en) | Drug for treating apoplexy sequela | |
| CN101972351B (en) | Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura | |
| CN102441144B (en) | Traditional Chinese medicament for treating infantile malnutrition | |
| CN104257982A (en) | Traditional Chinese medicine preparation for treating chloasma | |
| CN103520543A (en) | Traditional Chinese medicinal composition for treating facioplegia | |
| CN102274482A (en) | Chinese medicinal preparation for treating diabetes | |
| CN104435866A (en) | Traditional Chinese medicine composition for stopping bleeding for large-area wound | |
| CN103550604A (en) | Traditional Chinese medicine for treating neurodermatitis | |
| CN105749172A (en) | Medicament for treating gastric calculus and preparation thereof | |
| CN104257986A (en) | Traditional Chinese medicine for treating nephritis | |
| CN104436098A (en) | Traditional Chinese medicine preparation for treating multiple intestinal polyps | |
| CN103920105A (en) | Traditional Chinese medicinal composition for treating gallbladder channel stagnated heat type rhinitis | |
| CN103330760A (en) | Medicament used for treating allergic purpura | |
| CN103127398B (en) | Chinese medicament for treating cancers and preparation method thereof | |
| CN105456651A (en) | Medicine used for treating hair loss caused by blood deficiency cachexia and blood stasis | |
| CN105596648A (en) | Compound traditional Chinese medicine preparation for treating gallstone pain and preparation method thereof | |
| CN104127741A (en) | Traditional Chinese medicine formula for treating diabetes | |
| CN104352858B (en) | A kind of Chinese medicine composition for the treatment of infantile diarrhea | |
| CN104474253A (en) | Traditional Chinese medicine composition for treating chronic rhinitis | |
| CN104815306A (en) | Medicine for treating acute cholecystitis and preparation method thereof | |
| CN104398829A (en) | Traditional Chinese medicine paste with whitening and beautifying effects and preparation method thereof | |
| CN104474507A (en) | Medicine for treating urticaria and preparation method of medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111005 Termination date: 20120927 |